Sirolimus as a vascular malformation medicine

Sirolimus as a vascular malformation medicine

Sirolimus as a Treatment Option for EHEПодробнее

Sirolimus as a Treatment Option for EHE

Biomarkers, Genetics & Treatment of Generalized Lymphatic Anomaly & Kaposiform LymphangiomatosisПодробнее

Biomarkers, Genetics & Treatment of Generalized Lymphatic Anomaly & Kaposiform Lymphangiomatosis

#STEPProgram S1E8: Management of Vascular Malformations, by Dr V S Valarmathy / Dr Ashish GuptaПодробнее

#STEPProgram S1E8: Management of Vascular Malformations, by Dr V S Valarmathy / Dr Ashish Gupta

Dr. Denise Adams, Children's Hospital Philadelphia, speaks on PTEN-related vascular anomalies.Подробнее

Dr. Denise Adams, Children's Hospital Philadelphia, speaks on PTEN-related vascular anomalies.

Adrienne Hammill: Sirolimus Update and New Agents on the HorizonПодробнее

Adrienne Hammill: Sirolimus Update and New Agents on the Horizon

An Update on Lymphatic Anomalies: Classification and Treatment Options - Denise Adams, MD - LE&RNПодробнее

An Update on Lymphatic Anomalies: Classification and Treatment Options - Denise Adams, MD - LE&RN

Use of Sirolimus in GLA/GSD/KLAПодробнее

Use of Sirolimus in GLA/GSD/KLA

Options to Improve Endovascular Treatment of Claudication and CLI - UCSF Vascular Surgery SymposiumПодробнее

Options to Improve Endovascular Treatment of Claudication and CLI - UCSF Vascular Surgery Symposium

Contemporary Management of Complex Vascular Anomalies - Randolph LectureПодробнее

Contemporary Management of Complex Vascular Anomalies - Randolph Lecture

Sirolimus Therapy: What I Need to Know; What My Physician Needs to KnowПодробнее

Sirolimus Therapy: What I Need to Know; What My Physician Needs to Know